Literature DB >> 26392085

Th1-, Th2-, and Th17-associated cytokine expression in hypopharyngeal carcinoma and clinical significance.

Xuemei Chen1, Junfu Wang2, Rui Wang3, Qinghong Su2, Junwen Luan2, Haiyan Huang2, Peng Zhou2, Jinsheng Liu2, Xiaoqun Xu4.   

Abstract

Th0 cells differentiate into Th1 or Th2 depending on multiple transcription factors acting on specific time points to regulate gene expression. Th17 cells, a subset of IL-17-producing T cells distinct from Th1 or Th2 cells, have been described as key players in inflammation and autoimmune diseases as well as cancer development. In the present study, 53 patients with hypopharyngeal cancer were included. The expression levels of Th1-, Th2- and Th17-associated cytokines in hypopharyngeal cancer tissues and pericarcinoma tissues were detected. The relationship between Th1, Th2, or Th17 infiltration and metastasis was studied. Our results showed that the mRNA and protein expressions of Th1 cytokines were lower, while the expressions of Th2 and Th17 cytokines were higher in tumor tissues, and the intensity of expression was strengthened with clinical stage increasing. Cancer tissues had higher level expressions of Th2 and Th17 cytokines than that of pericarcinoma tissues. From the above data, we speculated that high expressions of Th2- and Th17-associated cytokines in hypopharyngeal carcinoma may contribute to cancer development and metastasis.

Entities:  

Keywords:  Cytokine; Hypopharyngeal carcinoma; Th1; Th17; Th2

Mesh:

Substances:

Year:  2015        PMID: 26392085     DOI: 10.1007/s00405-015-3779-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  46 in total

1.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

2.  An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer.

Authors:  Y M Chen; W K Yang; J Whang-Peng; C M Tsai; R P Perng
Journal:  Lung Cancer       Date:  2001-01       Impact factor: 5.705

3.  Metastatic patterns in squamous cell cancer of the head and neck.

Authors:  C Kotwall; K Sako; M S Razack; U Rao; V Bakamjian; D P Shedd
Journal:  Am J Surg       Date:  1987-10       Impact factor: 2.565

4.  Tumor microenvironments direct the recruitment and expansion of human Th17 cells.

Authors:  Xinming Su; Jian Ye; Eddy C Hsueh; Yanping Zhang; Daniel F Hoft; Guangyong Peng
Journal:  J Immunol       Date:  2009-12-21       Impact factor: 5.422

5.  Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer.

Authors:  Takanori Maruyama; Koji Kono; Yoshiki Mizukami; Yoshihiko Kawaguchi; Kousaku Mimura; Mitsuaki Watanabe; Shinichirou Izawa; Hideki Fujii
Journal:  Cancer Sci       Date:  2010-09       Impact factor: 6.716

Review 6.  Transforming growth factor-beta and the immune response: implications for anticancer therapy.

Authors:  Stephen H Wrzesinski; Yisong Y Wan; Richard A Flavell
Journal:  Clin Cancer Res       Date:  2007-09-15       Impact factor: 12.531

7.  National Cancer Database report on cancer of the head and neck: 10-year update.

Authors:  Jay S Cooper; Kim Porter; Katherine Mallin; Henry T Hoffman; Randal S Weber; Kian K Ang; E Greer Gay; Corey J Langer
Journal:  Head Neck       Date:  2009-06       Impact factor: 3.147

8.  Interleukin (IL)-17 promotes macrophages to produce IL-8, IL-6 and tumour necrosis factor-alpha in aplastic anaemia.

Authors:  Yan Gu; Xiaojing Hu; Chuanfang Liu; Xun Qv; Conggao Xu
Journal:  Br J Haematol       Date:  2008-05-08       Impact factor: 6.998

9.  NKG2D ligands expression and NKG2D-mediated cytotoxicity in human laryngeal squamous carcinoma cells.

Authors:  X M Chen; X Q Xu; K Sun; W H D Hallett; J D Zhao; D L Zhang
Journal:  Scand J Immunol       Date:  2008-02-27       Impact factor: 3.487

10.  The prevalence of Th17 cells in patients with gastric cancer.

Authors:  Bin Zhang; Guanghua Rong; Huafeng Wei; Meng Zhang; Jianwei Bi; Liye Ma; Xuchao Xue; Guo Wei; Xiaokang Liu; Guoen Fang
Journal:  Biochem Biophys Res Commun       Date:  2008-07-23       Impact factor: 3.575

View more
  4 in total

1.  Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.

Authors:  M Rita I Young; Corinne A Levingston; Sara D Johnson
Journal:  Int J Cancer       Date:  2016-01-28       Impact factor: 7.396

2.  Th17 Cells in Protection from Tumor or Promotion of Tumor Progression.

Authors:  M Rita I Young
Journal:  J Clin Cell Immunol       Date:  2016-06-20

3.  HNSCC subverts PBMCs to secrete soluble products that promote tumor cell proliferation.

Authors:  Marcell Costa de Medeiros; Rajat Banerjee; Min Liu; Giovana Anovazzi; Nisha J D'Silva; Carlos Rossa Junior
Journal:  Oncotarget       Date:  2017-06-15

Review 4.  Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance.

Authors:  Łukasz Zadka; Damian J Grybowski; Piotr Dzięgiel
Journal:  Cell Oncol (Dordr)       Date:  2020-06-02       Impact factor: 6.730

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.